top of page
News & Events
Boston ONS supports oncology programs and is now offering event management packages to best suit your program needs. Check it out!
- Tue, Jul 15
Search
Lunch and learn: Outcomes in patients younger than 50 years old with treatment naïve blastic plasmacytoid dendritic cell
Join us for a wonderful lunch and learn event Tuesday, July 15th at 2pm EST. Presented by: Jessie Signorelli, PharmD, BCOP. Hematology...
Jun 271 min read
EVENT NEXT WEEK!!!
Don't miss an excellent night out discussing CAR Therapy Management! Are you ready for your next patient? You are cordially invited to...
Jun 21 min read
AYVAKIT & Indolent Systemic Mastocytosis ~ August 6th @ Grill 23 & Bar
Click here to register.
May 181 min read
Iwilfin (DFMO) Maintenance treatment for High Risk Neuroblastoma ~ May 22nd, 2025
Join us at Joe's On Newbury on May 22nd at 6:30pm for a great review of Iwilfin for High Risk Neuroblastoma
May 41 min read
CAR-Therapy Adverse Reaction Identification and Management Considerations ~ Thursday, June 12th @ Davio's
Join other Boston ONS members for another excellent review of CAR-Therapy Adverse Reactions Review! Click here to register!
Apr 151 min read
NEW EVENT: Exploring the Role of NUBEQA (darolutamide) in mHSPC in Combination with Docetaxel and in nmCRPC PP-NUM-US-3389-1
Check out this new event and grab a seat!
Apr 121 min read
NEW EVENT! Make a Change in cGVHD Treatment Strategy and Provide Rapid, Durable Responses ~ March 19th, 2025 at Joe's on Newbury
Register and learn more! See attached flyer to share with colleagues and learn more.
Feb 61 min read
Ovarian Function Suppression in HR+ Premenopausal Advanced Breast Cancer ~ NOW December 18th, 2024
NEW UPDATE! To register, email Trish Ferrier at trish.ferrier@tersera.com .
Nov 26, 20241 min read
LUNCH & LEARN ~ Advanced Systemic Mastocytosis and the APEX Clinical Trial ~ Tuesday, 12/3/24
Hosted by:
Nov 24, 20241 min read
Exploring Time Off Treatment with a BCL-2 Inhibitor ~ Thursday, Nov 7th
Click here to learn more and register!
Oct 31, 20241 min read
The First and Only Novel Targeted Therapy Approved for mCRC, Regardless of Mutation Status, in More Than a Decade1-3
Click here to learn more and register!
Oct 8, 20241 min read
Unlocking the Potential for a Bispecific Antibody in 3L+ DLBCL and 3L+FL ~ Wednesday, October 23rd
Click here to register and learn more! Presented by: Tara Graff, DO Mission Blood + Cancer, Des Moines, Iowa
Oct 8, 20241 min read
Combined Power to Change the Game: RYBREVANT® + LAZCLUZE™ in First-Line Treatment of EGFR+* Locally Advanced or mNSCLC ~ Thursday, 10/24/24
Click here to register and learn more! Presented by: Mark Socinski, MD Executive Medical Director AdventHealth Cancer Institute, Orlando,...
Oct 8, 20241 min read
A Step Forward - Initiating VENCLEXTA Treatment in Patients with CLL - October 22nd @ 5:30pm
Click here to learn more and register!
Oct 4, 20241 min read
Diffuse Large B Cell Lymphoma Update ~ LIVE ~ October 22nd, 6-8pm
Join us on Tuesday, October 22nd, from 6-8pm at Joe's On Newbury for a wonderful overview of Diffuse Large B Cell Lymphoma. Presented by...
Sep 29, 20241 min read
A Path Forward in Managing AML - NEW VIRTUAL EVENT - 10/1/24
Register with BONS! Click here
Sep 24, 20241 min read
Virtual Job Fair ~ Dana-Farber Cancer Institute ~ September 10th, 2024
Looking for a new job or change in specialty practice!? Join Dana-Farber's Career Fair Tuesday, September 10th from 6-7pm. Printable...
Aug 25, 20241 min read
NEW EVENT! Live presentation on the latest data for Libtayo
REGISTER Check out this upcoming event! Hosted by Regeneron Register today via Boston ONS. More details shared through registration.
Aug 25, 20241 min read
Aug 8, 20240 min read
bottom of page